Skip to content

Multicenter Clinical Observation of Bingqing Essential Oil in the Treatment of Vascular Pathway Related Infections

Multicenter Clinical Observation of Bingqing Essential Oil in the Treatment of Vascular Pathway Related Infections

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023911
Enrollment
Unknown
Registered
2019-06-17
Start date
2019-08-30
Completion date
Unknown
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Pathway Infection

Interventions

Sponsors

The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who have been treated with regular hemodialysis for 3 months or more, who meet the diagnostic criteria of uremia stage of chronic renal failure; (2) Infection of internal fistula: including infection of puncture point and surrounding skin, infection of surgical incision suture and skin surface-related infection of internal fistula vascular connection. The clinical manifestations are local pain, tenderness, congestion, swelling, exudation of bloody or purulent secretions, skin ulceration. (3) Graft-related infections: infection of the puncture site and surrounding skin without involving the graft. The clinical manifestations were local pain, tenderness, congestion, swelling, exudation of hemocyanin or purulent secretion, skin ulceration at the infected site. (4) Catheter-related infections: Catheter-related infections: Catheter-related infections: pyorrhea, swelling, induration and/or tenderness within 2 cm or so of the outlet, and exudation of local secretions increased; Catheter-related tunnel infections: redness, tenderness, fever and systemic symptoms along the catheter, and pus may flow out from the catheter-related mouth when squeezing the tunnel; and with or without catheter-related bacteremia; (5) The age of the patients ranged from 18 to 80 years, with no gender limitation. (6) To participate in the study with informed consent and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Mental disorders, cognitive impairment, can not cooperate with the study smoothly; (2) coagulation dysfunction, has a significant tendency to bleed; (3) autoimmune deficiency; (4) allergic constitution or allergic to a variety of drugs; (5) poor compliance.

Design outcomes

Primary

MeasureTime frame
Relevant clinical symptoms and signs scale;Safety indicators;

Countries

China

Contacts

Public ContactJuan Xie

The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

477935578@qq.com+86 15985110288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026